Arteris Revenue Beats, But Losses Widen

Arteris (AIP) reported fiscal 2026 Q2 earnings on Aug 06th, 2026. The company delivered a revenue beat of $651,900 against consensus estimates, driven by strong enterprise and automotive demand. However, the EPS miss and widened net loss tempered the positive sentiment. Management raised full-year revenue guidance, signaling confidence in future growth despite current profitability challenges.

Revenue

The total revenue of Arteris increased by 46.2% to $24.13 million in 2026 Q2, up from $16.50 million in 2025 Q2.

Earnings/Net Income

Arteris's losses deepened to $0.30 per share in 2026 Q2 from a loss of $0.22 per share in 2025 Q2 (36.4% wider loss). Meanwhile, the company's net loss widened to $-14.06 million in 2026 Q2, representing a 54.1% increase from the $-9.13 million loss recorded in 2025 Q2. The Company has sustained losses for 6 years over the corresponding fiscal quarter, highlighting ongoing financial headwinds. The EPS performance was poor, as the company missed consensus estimates and widened its net loss significantly year-over-year.

Price Action

The stock price of Arteris has climbed 5.88% during the latest trading day, has climbed 7.92% during the most recent full trading week, and has edged up 0.96% month-to-date.

Post Earnings Price Action Review

While the logic for trading earnings beats can be backtested, a robust multi-quarter analysis for AIP is currently limited by the available dataset, which only includes one earnings release: August 6, 2026. This quarter saw a revenue surprise of $651,900.

Clarification is necessary: AIP refers to Arteris, not Applied Digital (APPLD). The August 6, 2026, earnings were released after market close, resulting in a revenue beat but an EPS miss of -0.06. Consequently, a strategy buying solely on revenue beats would have triggered, though the EPS miss likely weakened overall sentiment. A genuine 30-day backtest requires a broader dataset including clear beat definitions, multiple qualifying dates, and 30-day price returns adjusted for initial noise. With only one qualifying beat date currently available, statistically significant conclusions such as average 30-day returns cannot be derived. To proceed, one could either backtest a broader universe of U.S. stocks or expand AIP’s historical data. For AIP specifically, the mixed signal of a revenue beat coupled with an EPS miss suggests that the next 30 days will be more influenced by guidance, backlog, and analyst tone than revenue alone.

CEO Commentary

Charlie Janac, Chief Executive Officer, reported record-breaking Q2 2026 results, highlighting a 44% year-over-year increase in annual contract value plus royalties to $99.5 million and strong revenue growth driven by enterprise computing and automotive sectors. He emphasized that the majority of customer design starts supported AI or high-performance computing use cases, with data center chip development remaining a key revenue driver. Strategic wins included standardizing Arteris technology for a major hyperscale cloud company and deploying FlexGen smart NoC IP for chiplets. Janac also highlighted the expanded partnership with Arm for Cycuity cybersecurity assurance as a greenfield opportunity. He expressed optimism about Arteris’ position across data centers, edge devices, and physical AI, noting that the company is well-equipped to support growing semiconductor applications in the AI era while maintaining diversified customer relationships.

Guidance

Nick Hawkins, Chief Financial Officer, provided forward-looking statements for the remainder of 2026. For Q3 2026, the company expects revenue of $24 million to $25 million, ACV plus royalties of $99 million to $103 million, and a non-GAAP operating loss between $1 million and $3 million. For the full year 2026, guidance was raised to $95 million to $98 million in revenue, representing a 37% year-over-year increase at the midpoint. The company expects ACV plus royalties to exit the year at $102 million to $106 million, with a non-GAAP operating loss projected between $7 million and $10 million. Non-GAAP free cash flow is guided to be positive $5 million to $9 million. Management anticipates achieving non-GAAP operating profitability as early as Q4 2026, citing strong H2 momentum and operating leverage.

Additional News

Arteris shares have surged approximately 99.6% year-to-date, significantly outperforming the S&P 500’s 12.8% gain. Despite this strong performance, the stock carries a Zacks Rank #3 (Hold), reflecting mixed earnings estimate revisions ahead of the report. Historically, Arteris has demonstrated resilience in beating consensus revenue estimates, having topped them in four of the last four quarters. However, EPS performance has been more volatile, with a recent -100% surprise due to a wider-than-expected loss. The sustainability of the stock’s momentum will likely hinge on management’s commentary regarding future guidance and the broader semiconductor market’s demand for AI-related chiplet technologies. Investors are advised to monitor earnings estimate revisions closely, as they correlate strongly with near-term price movements. No significant M&A activity, executive changes, or dividend announcements were reported in the immediate vicinity of the earnings release.